Product Details Supplier Info More products

Inov8 Science has published results of trials in offices that show its AD (Air Disinfection) units substantially reduce airborne bioburden – an indicative measure of the bugs that cause colds and flu.

The air-disinfection trials were conducted at the offices of a large financial services company in Carlisle.

The trial was undertaken over a two-week period in July in an office measuring 1500 square feet and populated by 15 people.

Baseline samples were taken before running an AD unit in the office for one week.

The results clearly demonstrated the ability of the AD unit to substantially reduce the airborne threat of infection in an office.

Dr Ian Widger, science chief-technology officer at Inov8, said: ‘Even though the trials were conducted in the summer when bioburden levels were low, we have still demonstrated a reduction in airborne bioburden by more than two thirds.

‘We would expect a much greater effect in the winter when office windows are closed and higher background levels of colds and flu are prevalent.’ Inov8 Science claims its AD (Air Disinfection) unit can prevent disruptions by helping to protect staff, visitors and customers from swine flu.

Trials on the AD technology at the Health Protection Agency Porton Down Laboratory have demonstrated a 99.999 per cent kill of surrogate organisms such as the MS2 Coliphage and S.

Epidermidis.

Similarly, trials at Leeds University have shown dramatic levels of pathogen reduction in aerobiological chambers that were dosed with Staphylococcus Aureus and Clostridium Difficile.

View full profile